Related references
Note: Only part of the references are listed.Primary cervical screening with high risk human papillomavirus testing: observational study
Matejka Rebolj et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study
Kimberley Kavanagh et al.
LANCET INFECTIOUS DISEASES (2017)
Use of HPV testing for cervical screening in vaccinated womenInsights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study
Ramya Bhatia et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
Matejka Rebolj et al.
PLOS ONE (2016)
HPV primary cervical screening: time for a change
H. C. Kitchener
CYTOPATHOLOGY (2015)
Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance
Warner K. Huh et al.
GYNECOLOGIC ONCOLOGY (2015)
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2015)
Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany
Thomas Iftner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Beware of Kinked Frontiers: A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening
James F. O'Mahony et al.
VALUE IN HEALTH (2015)
Prospective follow-up of 2,065 young unscreened women to study human papillomavirus incidence and clearance
C. E. Schmeink et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study
Unnop Jaisamrarn et al.
PLOS ONE (2013)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
Debbie Saslow et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
Susanne K. Kjaer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Prevalence, Acquisition, and Clearance of Cervical Human Papillomavirus Infection among Women with Normal Cytology: Hawaii Human Papillomavirus Cohort Study
Marc T. Goodman et al.
CANCER RESEARCH (2008)
Heterogeneity in CIN3 diagnosis
Mark Shiffman et al.
LANCET ONCOLOGY (2008)
Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
Margaret R. E. McCredie et al.
LANCET ONCOLOGY (2008)
The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses - An ALTS report
Philip E. Castle et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
MJ Khan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Re: A study of the impact of adding HPV types to cervical cancer screening and triage tests
S Franceschi et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Extended duration of the detectable stage by adding HPV test in cervical cancer screening
ME van den Akker-van Marie et al.
BRITISH JOURNAL OF CANCER (2003)
Share Paper
